{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T07:51:23Z","timestamp":1786607483412,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T00:00:00Z","timestamp":1795219200000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["1R01DK124502"],"award-info":[{"award-number":["1R01DK124502"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["1R01DK140473"],"award-info":[{"award-number":["1R01DK140473"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["1R01DK142211"],"award-info":[{"award-number":["1R01DK142211"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["X01DK131477"],"award-info":[{"award-number":["X01DK131477"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ajpath.2025.08.011","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T03:13:28Z","timestamp":1757733208000},"page":"2411-2430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Stromal Steroid 5 Alpha-Reductase 2 Promotes Prostate Growth through WNT5A\u2013Lymphoid Enhancer\u2013Binding Factor 1\u2013Insulin-Like Growth Factor 1 Signaling in Benign Prostatic Hyperplasia"],"prefix":"10.1016","volume":"195","author":[{"given":"Christina","family":"Sharkey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1521-9608","authenticated-orcid":false,"given":"Boqing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingbo","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Patsatzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7223-9506","authenticated-orcid":false,"given":"Steven","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aria F.","family":"Olumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2025.08.011_bib1","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.ajpath.2013.02.028","article-title":"Androgen receptor roles in the development of benign prostate hyperplasia","volume":"182","author":"Izumi","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2025.08.011_bib2","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJM197405162902001","article-title":"Familial incomplete male pseudohermaphroditism, type 1: evidence for androgen resistance and variable clinical manifestations in a family with the Reifenstein syndrome","volume":"290","author":"Wilson","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2025.08.011_bib3","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1210\/jc.2003-030330","article-title":"Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor","volume":"89","author":"Clark","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajpath.2025.08.011_bib4","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1172\/JCI115954","article-title":"Molecular genetics of steroid 5 alpha-reductase 2 deficiency","volume":"90","author":"Thigpen","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2025.08.011_bib5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.urology.2004.01.001","article-title":"Efficacy and safety of dutasteride in the four-year treatment of men with benign prostatic hyperplasia","volume":"63","author":"Roehrborn","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.ajpath.2025.08.011_bib6","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"Medical Therapy of Prostatic Symptoms Research Group: The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2025.08.011_bib7","article-title":"Razumilava N: WNT signaling contributes to the extrahepatic bile duct proliferative response to obstruction in mice","volume":"10","author":"Calder","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.ajpath.2025.08.011_bib8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12015-023-10610-5","article-title":"WNT signaling in stem cells: a look into the non-canonical pathway","volume":"20","author":"Sarabia-Sanchez","year":"2024","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.ajpath.2025.08.011_bib9","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.stemcr.2023.04.003","article-title":"Modulation of the canonical Wnt activity by androgen signaling in prostate epithelial basal stem cells","volume":"18","author":"Horton","year":"2023","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.ajpath.2025.08.011_bib10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.stem.2019.03.010","article-title":"Spatially restricted stromal Wnt signaling restrains prostate epithelial progenitor growth through direct and indirect mechanisms","volume":"24","author":"Wei","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ajpath.2025.08.011_bib11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ydbio.2009.01.003","article-title":"The role of Wnt5a in prostate gland development","volume":"328","author":"Huang","year":"2009","journal-title":"Dev Biol"},{"key":"10.1016\/j.ajpath.2025.08.011_bib12","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1158\/0008-5472.CAN-07-6289","article-title":"Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity","volume":"68","author":"Placencio","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2025.08.011_bib13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1432-0436.2008.00277.x","article-title":"Molecular signaling pathways that regulate prostate gland development","volume":"76","author":"Prins","year":"2008","journal-title":"Differentiation"},{"key":"10.1016\/j.ajpath.2025.08.011_bib14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/path.6283","article-title":"Enhanced prostatic Esr1(+) luminal epithelial cells in the absence of SRD5A2","volume":"263","author":"Sharkey","year":"2024","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2025.08.011_bib15","series-title":"Guide for the care and use of laboratory animals: eighth edition","year":"2011"},{"key":"10.1016\/j.ajpath.2025.08.011_bib16","article-title":"Handling and assessment of human primary prostate organoid culture","volume":"143","author":"McCray","year":"2019","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ajpath.2025.08.011_bib17","first-page":"631","article-title":"Experimental prostate epithelial morphogenesis in response to stroma and three-dimensional matrigel culture","volume":"12","author":"Lang","year":"2001","journal-title":"Cell Growth Differ"},{"key":"10.1016\/j.ajpath.2025.08.011_bib18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth1015","article-title":"Three-dimensional culture models of normal and malignant breast epithelial cells","volume":"4","author":"Lee","year":"2007","journal-title":"Nat Methods"},{"key":"10.1016\/j.ajpath.2025.08.011_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.188062","article-title":"TIAM1 drives prostatic branching phenotype and is a potential therapeutic target for benign prostatic hyperplasia","volume":"10","author":"Khedmatgozar","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.ajpath.2025.08.011_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nprot.2016.170","article-title":"Generation of nephron progenitor cells and kidney organoids from human pluripotent stem cells","volume":"12","author":"Morizane","year":"2016","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ajpath.2025.08.011_bib21","doi-asserted-by":"crossref","DOI":"10.3791\/51998-v","article-title":"The soft agar colony formation assay","author":"Borowicz","year":"2014","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ajpath.2025.08.011_bib22","doi-asserted-by":"crossref","first-page":"7086","DOI":"10.1158\/0008-5472.CAN-04-1498","article-title":"Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand\u2013mediated apoptosis in prostate cancer","volume":"64","author":"Zhang","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2025.08.011_bib23","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2353\/ajpath.2007.070285","article-title":"Stromally expressed c-Jun regulates proliferation of prostate epithelial cells","volume":"171","author":"Li","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2025.08.011_bib24","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/JU.0000000000002332","article-title":"Zonal growth pattern of the prostate is affected by age and body mass index","volume":"207","author":"Sharkey","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.ajpath.2025.08.011_bib25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.aay0267","article-title":"Regenerative potential of prostate luminal cells revealed by single-cell analysis","volume":"368","author":"Karthaus","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2025.08.011_bib26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.diff.2020.12.001","article-title":"Developmental estrogenization: prostate gland reprogramming leads to increased disease risk with aging","volume":"118","author":"Prins","year":"2021","journal-title":"Differentiation"},{"key":"10.1016\/j.ajpath.2025.08.011_bib27","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/s41559-020-1157-y","article-title":"Stromal reactivity differentially drives tumour cell evolution and prostate cancer progression","volume":"4","author":"Frankenstein","year":"2020","journal-title":"Nat Ecol Evol"},{"key":"10.1016\/j.ajpath.2025.08.011_bib28","first-page":"5002","article-title":"Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium","volume":"59","author":"Olumi","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2025.08.011_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.diff.2015.10.006","article-title":"Mesenchymal-epithelial interaction techniques","volume":"91","author":"Cunha","year":"2016","journal-title":"Differentiation"},{"key":"10.1016\/j.ajpath.2025.08.011_bib30","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.59465","article-title":"A single-cell atlas of the mouse and human prostate reveals heterogeneity and conservation of epithelial progenitors","volume":"9","author":"Crowley","year":"2020","journal-title":"ELife"},{"key":"10.1016\/j.ajpath.2025.08.011_bib31","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/pros.24020","article-title":"Urethral luminal epithelia are castration-insensitive cells of the proximal prostate","volume":"80","author":"Joseph","year":"2020","journal-title":"Prostate"},{"key":"10.1016\/j.ajpath.2025.08.011_bib32","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1158\/0008-5472.CAN-03-0946","article-title":"Prostate pathology of genetically engineered mice: definitions and classification: the Consensus Report from the Bar Harbor Meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee","volume":"64","author":"Shappell","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2025.08.011_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13072-024-00550-w","article-title":"Transcriptional regulation mechanism of PARP1 and its application in disease treatment","volume":"17","author":"Lu","year":"2024","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.ajpath.2025.08.011_bib34","first-page":"1","article-title":"Role of PARP-1 in prostate cancer","volume":"3","author":"Deshmukh","year":"2015","journal-title":"Am J Clin Exp Urol"},{"key":"10.1016\/j.ajpath.2025.08.011_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135188","article-title":"Wnt\/beta-catenin-activated Ewing sarcoma cells promote the angiogenic switch","volume":"5","author":"Hawkins","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ajpath.2025.08.011_bib36","doi-asserted-by":"crossref","first-page":"9170","DOI":"10.1038\/s41467-024-53604-8","article-title":"IGF1 drives Wnt-induced joint damage and is a potential therapeutic target for osteoarthritis","volume":"15","author":"Escribano-N\u00fa\u00f1ez","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2025.08.011_bib37","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.juro.2006.11.095","article-title":"The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response","volume":"177","author":"Marks","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.ajpath.2025.08.011_bib38","first-page":"340","article-title":"Origin and evolution of benign prostatic enlargement","volume":"15","author":"McNeal","year":"1978","journal-title":"Invest Urol"},{"key":"10.1016\/j.ajpath.2025.08.011_bib39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jsbmb.2016.05.020","article-title":"Steroid 5[alpha]-reductase 2 deficiency","volume":"163","author":"Mendonca","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ajpath.2025.08.011_bib40","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/path.4985","article-title":"Androgenic to oestrogenic switch in the human adult prostate gland is regulated by epigenetic silencing of steroid 5[alpha]-reductase 2","volume":"243","author":"Wang","year":"2017","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2025.08.011_bib41","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.eururo.2007.10.052","article-title":"Type 1 and type 2 5alpha-reductase expression in the development and progression of prostate cancer","volume":"53","author":"Thomas","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajpath.2025.08.011_bib42","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1158\/0008-5472.CAN-10-1343","article-title":"Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer","volume":"71","author":"Mohler","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2025.08.011_bib43","first-page":"1389","article-title":"Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment","volume":"7","author":"Santiago","year":"2017","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.ajpath.2025.08.011_bib44","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/pros.24196","article-title":"Stromal cell interplay in prostate development, physiology, and pathological conditions","volume":"81","author":"Sanches","year":"2021","journal-title":"Prostate"},{"key":"10.1016\/j.ajpath.2025.08.011_bib45","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41585-024-00942-3","article-title":"Interactions between androgen and IGF1 axes in prostate tumorigenesis","volume":"22","author":"Adzavon","year":"2025","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.ajpath.2025.08.011_bib46","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.176479","article-title":"Spatial transcriptomics identifies candidate stromal drivers of benign prostatic hyperplasia","volume":"9","author":"Pollack","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.ajpath.2025.08.011_bib47","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1073\/pnas.97.7.3455","article-title":"Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice","volume":"97","author":"DiGiovanni","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2025.08.011_bib48","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1677\/JOE-08-0406","article-title":"Liver-derived IGF1 enhances the androgenic response in prostate","volume":"199","author":"Svensson","year":"2008","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ajpath.2025.08.011_bib49","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.1038\/s41467-022-34282-w","article-title":"Stromal androgen signaling acts as tumor niches to drive prostatic basal epithelial progenitor-initiated oncogenesis","volume":"13","author":"Hiroto","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2025.08.011_bib50","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1038\/s41467-022-32119-0","article-title":"Aberrant androgen action in prostatic progenitor cells induces oncogenesis and tumor development through IGF1 and Wnt axes","volume":"13","author":"Kim","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2025.08.011_bib51","first-page":"5474","article-title":"Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor","volume":"54","author":"Culig","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2025.08.011_bib52","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1158\/1078-0432.CCR-04-1586","article-title":"In vivo effects of the human type I insulin-like growth factor receptor antibody A12 on androgen-dependent and androgen-independent xenograft human prostate tumors","volume":"11","author":"Wu","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2025.08.011_bib53","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0090-4295(02)01905-2","article-title":"Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia","volume":"60","author":"Roehrborn","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.ajpath.2025.08.011_bib54","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.juro.2008.05.004","article-title":"Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over the full range of baseline prostate sizes in men enrolled in the MTOPS trial","volume":"180","author":"Kaplan","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.ajpath.2025.08.011_bib55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1756287215607419","article-title":"Fixed-dose combination therapy with dutasteride and tamsulosin in the management of benign prostatic hyperplasia","volume":"8","author":"Dimitropoulos","year":"2016","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.ajpath.2025.08.011_bib56","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajur.2021.04.002","article-title":"Efficacy of a combination of dutasteride, tadalafil, and solifenacin in the treatment of previously unsuccessful patients","volume":"9","author":"Kosilov","year":"2022","journal-title":"Asian J Urol"},{"key":"10.1016\/j.ajpath.2025.08.011_bib57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12894-019-0446-8","article-title":"Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia","volume":"19","author":"Zhou","year":"2019","journal-title":"BMC Urol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025003384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025003384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T21:38:13Z","timestamp":1773178693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944025003384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0002944025003384"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.08.011","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.05.22.655540","asserted-by":"object"}]},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stromal Steroid 5 Alpha-Reductase 2 Promotes Prostate Growth through WNT5A\u2013Lymphoid Enhancer\u2013Binding Factor 1\u2013Insulin-Like Growth Factor 1 Signaling in Benign Prostatic Hyperplasia","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Investigative Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}